Cargando…
Prognostic impact of p62 expression in cutaneous malignant melanoma
Autores principales: | Ellis, Robert A, Horswell, Stuart, Ness, Tom, Lumsdon, Jonathan, Tooze, Sharon A, Kirkham, Nigel, Armstrong, Jane L, Lovat, Penny E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954816/ https://www.ncbi.nlm.nih.gov/pubmed/24270664 http://dx.doi.org/10.1038/jid.2013.497 |
Ejemplares similares
-
Established and Emerging Biomarkers in Cutaneous Malignant Melanoma
por: Verykiou, Stamatina, et al.
Publicado: (2014) -
Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
por: Tang, Diana Y. L., et al.
Publicado: (2016) -
Health professional and patient views of a novel prognostic test for melanoma: A theoretically informed qualitative study
por: Lecouturier, Jan, et al.
Publicado: (2022) -
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
por: Sandru, Angela, et al.
Publicado: (2014) -
Cutaneous malignant melanoma in Scotland.
por: MacKie, R. M., et al.
Publicado: (1982)